In this review, we discuss in depth the essential role of CDK4/6is and their anticancer effects brought about by increased tumor cell immunogenicity, activation of effector T cells, induction of memory CD8+ T cells, and immunogenic cell death. This evidence concerns the gene CDK4 and neoplasm.